Case Western Reserve University School of Medicine researchers have evidence a vaccine against malaria will reduce infection and disease ratesDecember 21, 2007Today, researchers at the Case Western Reserve University School of Medicine's Center for Global Health & Diseases published data potentially having a strong effect on the three billion people exposed to malaria every year. Brian T. Grimberg, Peter A. Zimmerman and Christopher L. King published in the December issue of Public Library of Science Medicine, novel findings proving new antibodies inhibit infection by the Plasmodium vivax (P. vivax) malaria parasite. The research suggests a Duffy binding protein-based vaccine could provide protection against malaria blood-stage infection. This specific protein is an attractive candidate for a P. vivax vaccine, as it could decrease illness in malaria-prevalent regions. For the first time, scientists from the eight partner institutions along with the Center for Global Health & Diseases, conclusively proved that infiltration invasion of human red blood cells by the malaria parasite could be prevented by these antibodies. Unlike other types of malaria, a P. vivax infection relies solely upon on the single molecular interaction between the Duffy antigen on human red blood cells and the Duffy binding protein expressed by the parasite to establish the disease. By interrupting the interaction of parasite binding to the red cell, the researchers and their colleagues around the United States and in Papua New Guinea, India, and Thailand, have the potential to eliminate P. vivax malaria. By exploiting this required interaction, the research offers a clear path toward development of a P. vivax malaria vaccine.
James W. Kazura, director of the Center for the Case Western Reserve University Center for Global Health and Diseases, emphasized "P. vivax is widely distributed throughout Asia, the South Pacific, parts of Africa and South America. However, the importance of developing a vaccine against vivax malaria to the American public is underscored by the fact that this form of malaria is transmitted in Afghanistan, Iraq and adjoining regions where our troops are stationed." For more than 50 years the Case Western Reserve School of Medicine has dedicated significant effort to the field of international health. This emphasis was initiated by the late Frederick C. Robbins, dean of School of Medicine from 1966 to 1980, and Nobel laureate for discovering methods that led to development of the polio vaccine. Malaria, deemed one of the world's "big three" diseases, along with tuberculosis and HIV/AIDS, kills one million people every year. Currently, there are 70 million cases of P. vivax worldwide. The disease's prevalence has increased in recent years through the worldwide spread of drug resistance, which is why a vaccine is desperately needed. The research at Case Western Reserve University School of Medicine is particularly encouraging because it offers one of the first feasible vaccine concepts to the most common form of malaria. Case Western Reserve University | |||||||||||||||||||||
|
Related Malaria Current Events and Malaria News Articles Scientists decode genome of parasite that causes relapsing malaria Scientists have deciphered the complete genetic sequence of the parasite Plasmodium vivax, the leading cause of relapsing malaria, and compared it with the genomes of other species of malaria parasites. Common insecticide can decimate tadpole populations The latest findings of a University of Pittsburgh-based project to determine the environmental impact of routine pesticide use suggests that malathion--the most popular insecticide in the United States--can decimate tadpole populations by altering their food chain, according to research published in the Oct. 1 edition of Ecological Applications. Nanotech and synbio: Americans don't know what's coming A groundbreaking poll finds that almost half of U.S. adults have heard nothing about nanotechnology, and nearly nine in 10 Americans say they have heard just a little or nothing at all about the emerging field of synthetic biology, according to a new report released by the Project on Emerging Nanotechnologies (PEN) and Peter D. Hart Research. New way to make malaria medicine also first step in finding new antibiotics University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive. New UNC laboratory to help track and control tropical diseases The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods. Hidden infections crucial to understanding, controlling disease outbreaks Scientists and news organizations typically focus on the number of dead and gravely ill during epidemics, but research at the University of Michigan suggests that less dramatic, mild infections lurking in large numbers of people are the key to understanding cycles of at least one potentially fatal infectious disease: cholera. New insights could lead to a better pneumococcal vaccine Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). Purifying parasites with light Researchers have developed a clever method to purify parasitic organisms from their host cells, which will allow for more detailed proteomic studies and a deeper insight into the biology of organisms that cause millions of cases of disease each year. 'Dodgy dossier' partly to blame for failure of war against malaria in the tropics The war against malaria in tropical countries was fought and lost in the 20th Century on the basis of faulty intelligence, a 'dodgy dossier' which argued that the same methods used to tackle the disease in temperate countries would also work in the tropics. Best way to treat malaria: Avoid using same drug for everyone, scientists say A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||